Header

UZH-Logo

Maintenance Infos

Azilsartan


Gnädiger, M (2013). Azilsartan. Pharma Kritik, 35:pk893.

Abstract

Azilsartan (Edarbi®) ist der achte in der Schweiz erhältliche Angiotensin-II-Rezeptorantagonist (ein «Sartan») und wird zur Behandlung der arteriellen Hypertonie empfohlen.

Abstract

Azilsartan (Edarbi®) ist der achte in der Schweiz erhältliche Angiotensin-II-Rezeptorantagonist (ein «Sartan») und wird zur Behandlung der arteriellen Hypertonie empfohlen.

Statistics

Downloads

1 download since deposited on 18 Sep 2013
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Institute of General Practice
Dewey Decimal Classification:610 Medicine & health
Language:German
Date:2013
Deposited On:18 Sep 2013 11:43
Last Modified:05 Apr 2016 16:58
Publisher:Infomed-Verlags AG
ISSN:1010-5409
Official URL:http://www.infomed.ch/pk_template.php?pkid=893

Download

Preview Icon on Download
Content: Accepted Version
Filetype: PDF - Registered users only
Size: 131kB
Preview Icon on Download
Content: Published Version
Filetype: PDF - Registered users only
Size: 77kB

Article Networks

TrendTerms

TrendTerms displays relevant terms of the abstract of this publication and related documents on a map. The terms and their relations were extracted from ZORA using word statistics. Their timelines are taken from ZORA as well. The bubble size of a term is proportional to the number of documents where the term occurs. Red, orange, yellow and green colors are used for terms that occur in the current document; red indicates high interlinkedness of a term with other terms, orange, yellow and green decreasing interlinkedness. Blue is used for terms that have a relation with the terms in this document, but occur in other documents.
You can navigate and zoom the map. Mouse-hovering a term displays its timeline, clicking it yields the associated documents.

Author Collaborations